Posted by Melissa Altman
April 18th, 2012
West Palm Beach Partner Joel B. Rothman was a guest lecturer on April 12 at Northwestern University’s Medill School of Journalism, Media and Integrated Marketing Communications masters degree program. Mr. Rothman spoke to two sections of a graduate class entitled “Law, Policy & Media” and addressed topics on advertising law, claim substantiation, unfair/deceptive practices, and intellectual property issues. [...]
Posted by Hugo Ottolenghi
June 4th, 2010
The three little guys on Rice Krispies boxes are in trouble for claiming that their cereal supports the immune systems of children. The Federal Trade Commission announced on June 3 that Kellogg Co. had agreed to pull back on health claims for the puffy cereal. In a statement, commission chairman Jon Leibowitz said, “We expect [...]
Posted by Hugo Ottolenghi
November 12th, 2009
Should there be a language standard in Google ads for supplements? Drug marketers may adopt rules given the close scrutiny that the FDA is giving search-generated ads for pharmaceuticals. It may also be time for makers and marketers to set rules what is allowed.
Posted by Hugo Ottolenghi
August 9th, 2009
This time, the news report is real. We earlier identified News 13 and News 29 as being faux-TV news Web sites that touted the health benefits of resveratrol and acai. Now, CBS News — the real network — is reporting on what appears to be the same Hollywood-based company, FWM Laboratories, in a national broadcast and an accompanying Web story headlined, “Buyer Beware: Web Supplement Scams.”
Posted by Joel Rothman
June 23rd, 2009
The Nutritional and Dietary Supplement Law Blog is pleased as punch to announce that Joel B. Rothman, your faithful editor and publisher, has joined the West Palm Beach office of Arnstein & Lehr LLP as a partner. As many of our readers know, I devote a substantial portion of my practice to representing dietary supplement [...]
Posted by Hugo Ottolenghi
May 6th, 2009
The Food & Drug Administration issued on May 1 a consumer warning to stop using Hydroxycut, the heavily marketed weight-loss product. The agency said that “some Hydroxycut products are associated with a number of serious liver injuries” and announced that the maker was recalling all products. Did the FDA properly react? The warning cited 23 [...]
